Genetic variability of CYP2C9∗2 and CYP2C9∗3 in seven indigenous groups from Mexico

Article

Abstract: Aim: CYP2C9 is one of the major drug metabolizing enzymes, however, little is known about polymorphi

Palabras claves:

allele frequency, CYP2C9, hypoglycemic therapy, Mexican indigenous, pharmacogenetics, polymorphism

Autores:

Adrián LLerena, García-Rodríguez M., Granados-Silvestre M., Menjívar M., Ortiz-López M.G., Peña-Espinoza B., Rivera-Santiago C., Sánchez-Pozos K.

Fuentes:

scopus